بوابة الوسط
بوابة الوسط
Ready to play
Ready to play
The National Cancer Control Authority in Libya announced the arrival of a new shipment of specialized medications used in cancer treatment, aimed at supporting the continuity of healthcare services for patients and ensuring the availability of essential medicines. The shipment included drugs "Darzalex 400 mg" and "Orserdu 345 mg," as part of its efforts to strengthen cancer combatting initiatives. Additionally, another shipment of AstraZeneca’s medicines was distributed to nine different cancer treatment centers, including "Imfinzi," "Lynparza," "Tagrisso," and "Calquence," to assist in treating various types of cancers. The authority reaffirmed its ongoing monitoring of the treatment centers’ needs and its commitment to providing the necessary medications to support the continuity of treatment protocols.
Notice: This Is an AI-Generated Summary
Comments (0)